Form 8.3 - Allergan plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

3 February 2020

  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,576,626

(1.089%)

 

1,890

(0.001%)

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3,576,626

(1.089%)

 

1,890

(0.001%)

 
  1. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

(USD)

Sale

2,277

188.44

Sale

4,630

188.44

Sale

200

187.59

Sale

300

187.47

Sale

81

187.89

Sale

100

187.96

Sale

110

187.87

Purchase

3,832

188.44

Sale

13

188.44

Sale

228

187.76

Sale

139

188.16

Sale

176

188.49

Sale

100

187.84

Sale

800

188.10

Sale

300

188.46

Sale

310

187.80

Sale

300

188.13

Sale

153

188.07

Sale

33

188.56

Sale

100

188.18

Sale

269

188.28

Sale

211

188.19

Sale

460

188.22

Sale

100

188.02

Sale

100

188.51

Sale

200

188.38

Sale

100

188.43

Sale

100

188.12

Sale

5

188.08

Sale

100

188.20

Purchase

500

187.54

Sale

15

187.85

Purchase

50

187.61

Purchase

7,280

188.44

Purchase

15

187.82

Purchase

76

188.46

Purchase

100

187.53

Sale

10

188.03

Purchase

5

188.09

  1. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

  1. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

  1. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

4 February 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 691540
Time of Receipt (offset from UTC): 20200204T151335+0000

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.